Skip to main content

Notice

We are in the process of rolling out a soft launch of the RDA website, which includes a new member platform. Visitors may encounter functionality issues pertaining to group pages, navigation, missing content, broken links, etc. As you explore the new site, please provide your feedback using the UserSnap tool found throughout the site. Thank you in advance for your understanding and support as we work through all issues as quickly as possible.

ACTION REQUESTED: Share your Experiences Participating in the RDA COVID-19 WG (deadline 23 October)

  • Creator
    Discussion
  • #69663

    RDA Admin
    Member

    Hello Folks,
    Hope you are all healthy and safe. We would like to gently remind you about the survey gathering your feedback, by Friday’s deadline. Thank you to those who already have filled this out, and we look forward to learning from your experiences.
    Thank you again for your vital contributions to the effort to create the RDA COVID-19 Guidelines and Recommendations. As you may know, a group is working on a journal paper to describe and better understand the collaborative approach taken by the community to develop these guidelines, so that we can learn lessons for future collaborative projects. For us to do that, we need to hear from you!
    We would be grateful if you could take 10 minutes maximum to fill out the following survey, sharing your experiences and viewpoints on participating in the project, so that we can be sure to include your input: https://www.rd-alliance.org/rda-covid-19-community-participation-survey. Deadline: Friday, 23 October.
    Thank you in advance for your time and please let us know if you have any questions.
    Best wishes,
    Anu Gururaj, on behalf of the Collaborative Approach Paper Group
    Anupama Gururaj
    Program Officer,
    DAIT, NIAID, NIH
    5601 Fishers Ln., Room 7A76
    +1-240-472-2798 (m); +1-301-760-6608 (o)
    NIAID, NIH, HHS​
    Disclaimer: The information in this email and any of its attachments is confidential and may contain sensitive information. It should not be used by anyone who is not the originally intended recipient. If you have received this email in error, please inform the sender and delete it from your mailbox or any other storage devices. The National Institute of Allergy and Infectious Diseases shall not accept liability for any statements made that are the sender’s own and not expressly made on behalf of NIAID by one of its representatives.

Log in to reply.